New Perspectives specializes in helping emerging specialty pharma and biotech companies become more commercially-minded organizations. We work with our companies on commercial strategy and assist in executing those strategies.

New Perspectives can manage early activities like market and payer research, market access, and medical education to managed care activities, reimbursement strategy and even short-term commercial operations. We can function on a project basis or serve as members of the commercial team until companies are ready to bring certain aspects in house, thus reducing the risk of building too much infrastructure until there is more certainty with the program.

We have experience in multiple disease areas, as well as 505b(2) and orphan indications including setting up patient-focused programs (often in coordination with foundations) needed by rare diseases. We’ve launched multiple products in these areas.

By helping our clients develop purposeful product positioning with physicians & patients, reimbursement or payer strategies, and market assessments, we make sure you're maximizing the commercial potential of your asset - whether you are partnering or commercializing yourself.